Albireo Pharma Inc. buy Mori8
Start price
15.12.16
/
50%
€20.99
Target price
08.03.17
€26.05
Performance (%)
4.86%
End price
08.03.17
€22.01
Summary
This prediction ended on 08.03.17 with a price of €22.01. With a performance of 4.86%, the BUY prediction by Mori8 for Albireo Pharma Inc. closed with a slight gain. Mori8 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Albireo Pharma Inc. | - | - | - | - |
| iShares Core DAX® | -0,98 % | -4,72 % | 4,79 % | 53,02 % |
| iShares Nasdaq 100 | 1,16 % | 1,88 % | 20,23 % | 95,41 % |
| iShares Nikkei 225® | -1,59 % | -5,39 % | 31,35 % | 54,65 % |
| iShares S&P 500 | -0,28 % | 0,33 % | 13,91 % | 66,55 % |
Comments by Mori8 for this prediction
In the thread Albireo Pharma Inc. diskutieren
Mori8 stimmt der Buy-Einschätzung von Quitte zu
Mori8 stimmt am 15.12.2016 der Buy-Einschätzung von Quitte mit dem Kursziel 21€ zu.Überschrift: schuldenfrei und Merger in Sicht
Stopped prediction by Mori8 for Albireo Pharma Inc.
Albireo Pharma Inc.
Start price
Target price
Perf. (%)
€21.25
14.03.17
14.03.17
€28.28
13.07.17
13.07.17
5.88%
13.07.17
13.07.17
Albireo Pharma Inc.
Start price
Target price
Perf. (%)
€11.04
20.09.16
20.09.16
€17.64
14.12.16
14.12.16
111.06%
14.12.16
14.12.16